iwWM 2022 – Jorge Castillo

Jorge Castillo highlights the most relevant findings regarding chemoimmunotherapy in patients with Waldenström‘s Macroglobulinemia presented at the 11^th iwWM, discusses the management of WM patients who have been exposed to covalent BTK inhibitors, explains which clinical endpoint(s) should be reached in the treatment of patients with WM and shares his thoughts on promising novel treatment approaches.

Here is the full iwWM 2022 report.